Search

everythinglearnresearchcommunity

for

Search:↓

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Some drugs used to treat inflammation may cause hair loss.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Infliximab may cause hair loss in Crohn's disease patients.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Recognizing unusual symptoms in Crohn's disease is crucial for proper treatment.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Turkish pregnant women commonly experienced skin issues like itching and acne, and doctors mainly used topical treatments due to safety concerns during pregnancy.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disabilities.

Rituximab improved her dermatomyositis better than usual treatments.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Co-trimoxazole may help treat autoimmune diseases.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Blocking interferon-gamma might help treat various autoimmune diseases.

Bimekizumab can improve scarring alopecia in severe psoriasis.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.